Vapotherm, Inc. (VAPO): Price and Financial Metrics
VAPO Price/Volume Stats
| Current price | $0.61 | 52-week high | $3.54 |
| Prev. close | $0.62 | 52-week low | $0.41 |
| Day low | $0.59 | Volume | 83,484 |
| Day high | $0.66 | Avg. volume | 193,115 |
| 50-day MA | $0.59 | Dividend yield | N/A |
| 200-day MA | $1.24 | Market Cap | 28.19M |
VAPO Stock Price Chart Interactive Chart >
VAPO POWR Grades
- VAPO scores best on the Growth dimension, with a Growth rank ahead of 81.72% of US stocks.
- VAPO's strongest trending metric is Growth; it's been moving up over the last 139 days.
- VAPO ranks lowest in Quality; there it ranks in the 2nd percentile.
VAPO Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for VAPO is -2.81 -- better than just 3.94% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at -9.32 for VAPOTHERM INC; that's greater than it is for merely 2.34% of US stocks.
- In terms of volatility of its share price, VAPO is more volatile than 93.8% of stocks we're observing.
- Stocks that are quantitatively similar to VAPO, based on their financial statements, market capitalization, and price volatility, are AZYO, LVO, BBLN, AMRS, and MTCH.
- Visit VAPO's SEC page to see the company's official filings. To visit the company's web site, go to www.vapotherm.com.
VAPO Valuation Summary
- VAPO's price/sales ratio is 0.4; this is 81.82% lower than that of the median Healthcare stock.
- Over the past 55 months, VAPO's EV/EBIT ratio has gone up 6.8.
Below are key valuation metrics over time for VAPO.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| VAPO | 2023-05-23 | 0.4 | -1.2 | -0.3 | -1.1 |
| VAPO | 2023-05-22 | 0.4 | -1.2 | -0.3 | -1.1 |
| VAPO | 2023-05-19 | 0.5 | -1.3 | -0.3 | -1.1 |
| VAPO | 2023-05-18 | 0.4 | -1.2 | -0.2 | -1.0 |
| VAPO | 2023-05-17 | 0.4 | -1.2 | -0.3 | -1.1 |
| VAPO | 2023-05-16 | 0.5 | -1.3 | -0.3 | -1.1 |
VAPO's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- VAPO has a Quality Grade of F, ranking ahead of 3.49% of graded US stocks.
- VAPO's asset turnover comes in at 0.702 -- ranking 53rd of 186 Medical Equipment stocks.
- 500 - Internal server error
The table below shows VAPO's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-09-30 | 0.702 | 0.501 | -0.633 |
| 2021-06-30 | 0.636 | 0.505 | -0.633 |
| 2021-03-31 | 0.680 | 0.511 | -0.536 |
| 2020-12-31 | 0.688 | 0.501 | -0.623 |
| 2020-09-30 | 0.624 | 0.493 | -0.583 |
| 2020-06-30 | 0.572 | 0.480 | -0.610 |
Vapotherm, Inc. (VAPO) Company Bio
Vapotherm Inc. Vapotherm, Inc. is a global medical technology company. The Company is focused on the development and commercialization of its high velocity nasal insufflations (Hi-VNI) technology products that are used to treat patients suffering from respiratory distress. Its Hi-VNI technology delivers noninvasive ventilatory support by providing heated, humidified and oxygenated air at a high velocity to patients through a comfortable small-bore nasal interface. Its Precision Flow systems uses its Hi-VNI technology. It offers three versions of its Precision Flow systems: Precision Flow Plus, Precision Flow Classic and Precision Flow Heliox. Its Precision Flow systems include a capital unit, a single-use disposable and a nasal interface. Its Precision Flow versions are integrated systems that provide precise user control of temperature, air flow and percentage oxygen through a one-button interface.
Latest VAPO News From Around the Web
Below are the latest news stories about VAPOTHERM INC that investors may wish to consider to help them evaluate VAPO as an investment opportunity.
Vapotherm (VAPO) Reports Q1 Loss, Lags Revenue EstimatesVapotherm (VAPO) delivered earnings and revenue surprises of -9.76% and 4.39%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock? |
Vapotherm Reports First Quarter 2023 Financial ResultsEXETER, N.H., May 03, 2023--Vapotherm, Inc. (NYSE: VAPO), ("Vapotherm" or the "Company"), today announced first quarter 2023 financial results. |
Vapotherm To Report First Quarter 2023 Financial ResultsEXETER, N.H., April 27, 2023--Vapotherm, Inc. (NYSE: VAPO), ("Vapotherm" or the "Company"), today announced that it will release financial results for the first quarter of 2023 after the close of trading on Wednesday, May 3, 2023. Vapotherm’s management team will host a conference call beginning at 4:30 p.m. ET to discuss the financial results and recent business developments. |
7 Stocks to Sell in March Before They Crash and BurnAlthough it’s an uncomfortable and perhaps controversial topic, investors seeking success must address certain stocks to sell. |
Vapotherm Announces NYSE Continued Listing Standard Notice Related to Stock PriceEXETER, N.H., March 17, 2023--Vapotherm, Inc. (NYSE: VAPO), ("Vapotherm" or the "Company"), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering from respiratory distress, today announced that it was notified (the "Notice") on March 15, 2023 by the New York Stock Exchange, Inc. (the "NYSE") that the Company is not in compliance with the NYSE’s conti |
VAPO Price Returns
| 1-mo | 12.96% |
| 3-mo | -32.97% |
| 6-mo | -62.35% |
| 1-year | -81.11% |
| 3-year | -97.71% |
| 5-year | N/A |
| YTD | -77.41% |
| 2022 | -86.96% |
| 2021 | -22.90% |
| 2020 | 120.89% |
| 2019 | -39.05% |
| 2018 | N/A |
Loading social stream, please wait...